A One Stop Shop for Everything Futures Trading

From RJO Futures | Ad

Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!

Download your FREE Technical Analysis Trading Guide Today.

YMAB Insider Trading (Y-mAbs Therapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 20.61%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $9,716,067.33

Y-mAbs Therapeutics Insider Trading History Chart

Y-mAbs Therapeutics Share Price & Price History

^$18.30

▲ +0.9 (5.17%)

As of 08/12/2022 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Click here now!

Y-mAbs Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/22/2022	Bo Kruse	CFO	Sell	4,000	$7.85	$31,400.00
2/9/2022	Thomas Gad	Insider	Sell	64,276	$6.96	$447,360.96
2/7/2022	Thomas Gad	Insider	Sell	91,031	$7.59	$690,925.29
2/4/2022	Bo Kruse	CFO	Sell	4,000	$7.97	$31,880.00
2/3/2022	Thomas Gad	Insider	Sell	35,060	$7.90	$276,974.00
2/1/2022	Thomas Gad	Insider	Sell	8,000	$10.15	$81,200.00
1/24/2022	Bo Kruse	CFO	Sell	4,000	$9.84	$39,360.00
1/24/2022	Thomas Gad	Insider	Sell	88,055	$10.63	$936,024.65
1/20/2022	Thomas Gad	Insider	Sell	112,767	$11.33	$1,277,650.11
1/18/2022	Thomas Gad	Insider	Sell	8,000	$11.54	$92,320.00
1/4/2022	Bo Kruse	CFO	Sell	4,000	$17.12	$68,480.00
12/22/2021	Bo Kruse	CFO	Sell	4,000	$16.36	$65,440.00
12/6/2021	Bo Kruse	CFO	Sell	4,000	$16.35	$65,400.00
12/6/2021	Thomas Gad	Insider	Sell	44,000	$16.48	$725,120.00
11/29/2021	Thomas Gad	Insider	Sell	22,437	$17.16	$385,018.92
11/23/2021	Thomas Gad	Insider	Sell	50,000	$17.06	$853,000.00
11/22/2021	Bo Kruse	CFO	Sell	4,000	$18.09	$72,360.00
11/16/2021	Thomas Gad	Insider	Sell	4,000	$19.33	$77,320.00
10/29/2021	Thomas Gad	Insider	Sell	4,000	$24.82	$99,280.00
10/22/2021	Bo Kruse	CFO	Sell	4,000	$25.94	$103,760.00
10/15/2021	Thomas Gad	Insider	Sell	4,000	$27.20	$108,800.00
10/4/2021	Bo Kruse	CFO	Sell	4,000	$28.78	$115,120.00
9/30/2021	Thomas Gad	Insider	Sell	4,000	$28.26	$113,040.00
9/22/2021	Bo Kruse	CFO	Sell	4,000	$30.82	$123,280.00
9/15/2021	Thomas Gad	Insider	Sell	4,000	$33.64	$134,560.00
9/7/2021	Bo Kruse	CFO	Sell	4,000	$32.03	$128,120.00	225,077
9/2/2021	Thomas Gad	Insider	Sell	50,000	$33.18	$1,659,000.00	50,000
8/23/2021	Bo Kruse	CFO	Sell	4,000	$28.60	$114,400.00
8/16/2021	Thomas Gad	Insider	Sell	26,111	$29.30	$765,052.30
8/13/2021	Thomas Gad	Insider	Sell	1,110	$31.01	$34,421.10
8/12/2021	Vignesh Rajah	CMO	Buy	1,374	$29.95	$41,151.30
8/4/2021	Bo Kruse	CFO	Sell	4,000	$33.72	$134,880.00
7/22/2021	Bo Kruse	CFO	Sell	4,000	$34.50	$138,000.00
7/22/2021	Bo Kruse	CFO	Sell	4,000	$34.50	$138,000.00
7/20/2021	Thomas Gad	Insider	Sell	4,000	$32.47	$129,880.00
7/6/2021	Bo Kruse	CFO	Sell	4,000	$34.15	$136,600.00
6/22/2021	Bo Kruse	CFO	Sell	4,000	$36.17	$144,680.00	245,077
6/14/2021	Thomas Gad	Insider	Sell	4,000	$35.80	$143,200.00
6/9/2021	Biotech Aps Wg	Director	Sell	116,700	$36.19	$4,223,373.00	4,306,394
6/7/2021	Biotech Aps Wg	Major Shareholder	Sell	72,400	$34.15	$2,472,460.00	4,306,394
6/4/2021	Biotech Aps Wg	Major Shareholder	Sell	3,841	$34.03	$130,709.23	4,415,935
6/4/2021	Bo Kruse	CFO	Sell	4,000	$33.48	$133,920.00	249,077
6/3/2021	Johan Wedell-Wedellsborg	Director	Sell	30,666	$33.19	$1,017,804.54	4,415,935
6/1/2021	Johan Wedell-Wedellsborg	Director	Sell	6,864	$35.57	$244,152.48	4,453,465
5/28/2021	Johan Wedell-Wedellsborg	Director	Sell	25,000	$36.34	$908,500.00	4,453,465
5/28/2021	Thomas Gad	Insider	Sell	4,000	$36.95	$147,800.00
5/24/2021	Bo Kruse	CFO	Sell	4,000	$35.61	$142,440.00	253,077
4/26/2021	Thomas Gad	Insider	Sell	7,000	$27.96	$195,720.00	7,000
4/12/2021	Thomas Gad	Insider	Sell	7,000	$26.61	$186,270.00	7,000
3/15/2021	Thomas Gad	Insider	Sell	7,000	$36.79	$257,530.00	7,000
1/19/2021	David N Gill	Director	Sell	2,000	$46.52	$93,040.00	2,000
1/19/2021	Thomas Gad	Insider	Sell	7,000	$46.51	$325,570.00	7,000
1/5/2021	Thomas Gad	Insider	Sell	7,000	$49.36	$345,520.00	7,000
12/28/2020	Thomas Gad	Insider	Sell	7,000	$51.98	$363,860.00	7,000
12/16/2020	Thomas Gad	Insider	Sell	7,000	$53.01	$371,070.00	7,000
12/14/2020	Thomas Gad	Insider	Sell	4,000	$52.89	$211,560.00
12/10/2020	Thomas Gad	Insider	Sell	50,000	$50.75	$2,537,500.00	50,000
12/2/2020	Pedro Claus Juan Moller-San	CEO	Sell	40,734	$51.27	$2,088,432.18	15,625
12/2/2020	Vignesh Rajah	CMO	Buy	233	$51.03	$11,889.99
12/1/2020	Thomas Gad	Chairman	Sell	4,000	$51.42	$205,680.00
11/17/2020	Vignesh Rajah	CMO	Buy	1,464	$45.74	$66,963.36
11/3/2020	David N Gill	Director	Sell	4,000	$45.00	$180,000.00	4,000
10/15/2020	Thomas Gad	Chairman	Sell	4,000	$39.15	$156,600.00
10/1/2020	Thomas Gad	Chairman	Sell	4,000	$38.88	$155,520.00
9/14/2020	Thomas Gad	Chairman	Sell	22,569	$41.00	$925,329.00	13,860
9/11/2020	Thomas Gad	Chairman	Sell	13,571	$40.33	$547,318.43	13,860
9/1/2020	Thomas Gad	Chairman	Sell	4,000	$41.60	$166,400.00
8/17/2020	Thomas Gad	Chairman	Sell	4,000	$40.35	$161,400.00
8/11/2020	Thomas Gad	Chairman	Sell	37,000	$40.06	$1,482,220.00
7/15/2020	Thomas Gad	Chairman	Sell	4,000	$40.06	$160,240.00
6/15/2020	Thomas Gad	Chairman	Sell	4,000	$43.45	$173,800.00
6/4/2020	Thomas Gad	Chairman	Sell	4,000	$41.61	$166,440.00
5/26/2020	Mahiuddin Ahmed	VP	Sell	50,000	$39.38	$1,969,000.00	150,000
5/13/2020	Bo Kruse	CFO	Sell	14,724	$37.86	$557,450.64	285,276
5/13/2020	Pedro Claus Juan Moller-San	CEO	Sell	60,846	$37.75	$2,296,936.50	15,625
5/12/2020	Mahiuddin Ahmed	VP	Sell	20,000	$39.19	$783,800.00	240,000
5/12/2020	Thomas Gad	Chairman	Sell	50,000	$39.04	$1,952,000.00
4/13/2020	Thomas Gad	Chairman	Sell	4,000	$29.43	$117,720.00
3/17/2020	Pedro Claus Juan Moller-San	CEO	Buy	1,900	$17.22	$32,718.00	15,625
3/16/2020	Thomas Gad	Chairman	Sell	4,000	$18.01	$72,040.00
2/10/2020	Thomas Gad	Chairman	Sell	4,000	$33.03	$132,120.00
1/27/2020	Thomas Gad	Chairman	Sell	4,000	$35.06	$140,240.00
1/13/2020	Thomas Gad	Chairman	Sell	4,000	$30.90	$123,600.00
12/16/2019	Thomas Gad	Chairman	Sell	4,000	$31.54	$126,160.00
12/2/2019	Thomas Gad	Chairman	Sell	4,000	$32.48	$129,920.00
11/18/2019	Thomas Gad	Chairman	Sell	4,000	$28.85	$115,400.00
11/4/2019	Thomas Gad	Chairman	Sell	4,000	$30.01	$120,040.00
10/30/2019	James Healy	Director	Buy	90,000	$29.79	$2,681,100.00
10/21/2019	Thomas Gad	Chairman	Sell	4,000	$31.65	$126,600.00
10/18/2019	Thomas Gad	CEO	Sell	7,250	$16.71	$121,147.50
10/7/2019	Thomas Gad	Chairman	Sell	4,000	$25.21	$100,840.00
9/16/2019	Thomas Gad	Chairman	Sell	4,000	$30.59	$122,360.00
9/6/2019	Johan Wedell-Wedellsborg	Director	Sell	17,243	$27.00	$465,561.00
9/3/2019	Thomas Gad	Chairman	Sell	4,000	$25.77	$103,080.00
8/30/2019	Johan Wedell-Wedellsborg	Director	Sell	89,166	$26.58	$2,370,032.28
8/28/2019	Johan Wedell-Wedellsborg	Director	Sell	49,357	$27.08	$1,336,587.56
8/21/2019	Johan Wedell-Wedellsborg	Director	Sell	168,244	$27.57	$4,638,487.08
8/19/2019	Thomas Gad	Insider	Sell	4,000	$27.70	$110,800.00

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for Y-mAbs Therapeutics (NASDAQ:YMAB)

60.50% of Y-mAbs Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Y-mAbs Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/13/2022	Zurcher Kantonalbank Zurich Cantonalbank	6,513	$99K	0.0%	+248.7%	0.015%
8/13/2022	Renaissance Technologies LLC	149,800	$2.27M	0.0%	+64.6%	0.343%
8/12/2022	Northern Trust Corp	333,098	$5.04M	0.0%	+1.8%	0.762%
8/12/2022	Ensign Peak Advisors Inc	42,152	$0.64M	0.0%	+871.2%	0.096%
8/12/2022	Credit Suisse AG	20,924	$0.32M	0.0%	+8.6%	0.048%
8/12/2022	Rafferty Asset Management LLC	50,596	$0.77M	0.0%	-63.9%	0.116%
8/12/2022	FMR LLC	1,970,851	$29.82M	0.0%	+0.0%	4.508%
8/12/2022	BNP Paribas Arbitrage SA	7,980	$0.12M	0.0%	+172.5%	0.018%
8/12/2022	Brandywine Global Investment Management LLC	21,300	$0.32M	0.0%	-12.7%	0.049%
8/12/2022	Rhumbline Advisers	43,511	$0.66M	0.0%	+20.6%	0.100%
8/11/2022	Deutsche Bank AG	70,336	$1.06M	0.0%	-76.9%	0.161%
8/11/2022	UBS Group AG	25,569	$0.39M	0.0%	-80.9%	0.058%
8/11/2022	JPMorgan Chase & Co.	32,664	$0.49M	0.0%	-22.8%	0.075%
8/10/2022	Principal Financial Group Inc.	10,595	$0.16M	0.0%	N/A	0.024%
8/9/2022	Swiss National Bank	77,100	$1.17M	0.0%	+24.4%	0.176%
8/9/2022	Lazard Asset Management LLC	5,655	$85K	0.0%	N/A	0.013%
8/8/2022	Walleye Capital LLC	416,140	$6.30M	0.2%	N/A	0.952%
8/8/2022	Rice Hall James & Associates LLC	91,898	$1.39M	0.1%	+1.7%	0.210%
8/5/2022	State Board of Administration of Florida Retirement System	15,096	$0.23M	0.0%	+35.3%	0.035%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	36,054	$0.55M	0.0%	+36.3%	0.082%
7/29/2022	SG Americas Securities LLC	18,217	$0.28M	0.0%	N/A	0.042%
7/26/2022	Mirae Asset Global Investments Co. Ltd.	11,186	$0.17M	0.0%	N/A	0.026%
7/25/2022	Allspring Global Investments Holdings LLC	4,628	$70K	0.0%	-74.6%	0.011%
7/25/2022	Strs Ohio	26,600	$0.40M	0.0%	+6.0%	0.061%
7/8/2022	DnB Asset Management AS	13,399	$0.20M	0.0%	N/A	0.031%
6/30/2022	Amalgamated Bank	5,706	$68K	0.0%	N/A	0.013%
6/7/2022	Bank of America Corp DE	398,823	$4.74M	0.0%	+386.8%	0.912%
5/18/2022	BNP Paribas Arbitrage SA	2,928	$35K	0.0%	-67.8%	0.007%
5/17/2022	Polar Capital Holdings Plc	2,877,671	$34.19M	0.2%	+108.9%	6.584%
5/17/2022	Royal Bank of Canada	9,471	$0.11M	0.0%	-25.6%	0.022%
5/16/2022	California State Teachers Retirement System	37,293	$0.44M	0.0%	-9.3%	0.085%
5/16/2022	Goldman Sachs Group Inc.	126,111	$1.50M	0.0%	-42.0%	0.288%
5/16/2022	Wellington Management Group LLP	1,910,578	$22.70M	0.0%	-55.3%	4.371%
5/16/2022	State Street Corp	2,308,782	$27.43M	0.0%	+58.5%	5.282%
5/16/2022	UBS Group AG	134,177	$1.59M	0.0%	+108.2%	0.307%
5/13/2022	Renaissance Technologies LLC	91,000	$1.08M	0.0%	-7.7%	0.208%
5/13/2022	Northern Trust Corp	327,253	$3.89M	0.0%	-4.9%	0.749%
5/13/2022	Charles Schwab Investment Management Inc.	233,756	$2.78M	0.0%	-4.5%	0.535%
5/13/2022	American International Group Inc.	17,350	$0.21M	0.0%	-6.6%	0.040%
5/13/2022	Ergoteles LLC	23,063	$0.27M	0.0%	+24.2%	0.053%
5/13/2022	Candriam Luxembourg S.C.A.	172,584	$2.05M	0.0%	-6.0%	0.395%
5/13/2022	Vanguard Group Inc.	1,794,510	$21.32M	0.0%	-1.2%	4.105%
5/13/2022	Dimensional Fund Advisors LP	183,368	$2.18M	0.0%	-4.4%	0.420%
5/12/2022	BlackRock Inc.	2,945,094	$34.99M	0.0%	+6.4%	6.737%
5/12/2022	Metropolitan Life Insurance Co NY	2,305	$27K	0.0%	-75.9%	0.005%
5/12/2022	MetLife Investment Management LLC	20,683	$0.25M	0.0%	+54.2%	0.047%
5/12/2022	Citigroup Inc.	30,402	$0.36M	0.0%	-55.1%	0.070%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	26,443	$0.31M	0.0%	N/A	0.060%
5/11/2022	JPMorgan Chase & Co.	42,322	$0.50M	0.0%	+12.6%	0.097%
5/10/2022	ProShare Advisors LLC	11,069	$0.13M	0.0%	-19.7%	0.025%
5/10/2022	CNA Financial Corp	25,450	$0.30M	0.1%	+39.6%	0.058%
5/9/2022	Swiss National Bank	62,000	$0.74M	0.0%	+8.2%	0.142%
5/5/2022	Rice Hall James & Associates LLC	90,375	$1.07M	0.0%	+7.1%	0.207%
5/5/2022	New York State Common Retirement Fund	24,579	$0.29M	0.0%	-89.6%	0.056%
4/28/2022	DekaBank Deutsche Girozentrale	14,400	$0.17M	0.0%	+9.9%	0.033%
4/21/2022	Strs Ohio	25,100	$0.30M	0.0%	N/A	0.057%
2/15/2022	Ashford Capital Management Inc.	226,180	$3.67M	0.4%	-50.0%	0.518%
2/14/2022	Lombard Odier Asset Management Switzerland SA	385,440	$6.25M	0.4%	+9.2%	0.883%
2/14/2022	Virtus ETF Advisers LLC	23,646	$0.38M	0.1%	+88.0%	0.054%
2/14/2022	Rice Hall James & Associates LLC	84,395	$1.37M	0.0%	-15.0%	0.193%
2/14/2022	Alliancebernstein L.P.	1,942,334	$31.49M	0.0%	+37.0%	4.450%
2/14/2022	Soleus Capital Management L.P.	310,494	$5.03M	0.5%	+16.9%	0.711%
2/14/2022	GSA Capital Partners LLP	69,311	$1.12M	0.1%	N/A	0.159%
2/11/2022	CNA Financial Corp	18,230	$0.30M	0.1%	+32.5%	0.042%
2/11/2022	Bioimpact Capital LLC	446,457	$7.24M	1.3%	-1.4%	1.023%
2/11/2022	Allianz Asset Management GmbH	29,754	$0.48M	0.0%	-20.3%	0.068%
2/10/2022	Candriam Luxembourg S.C.A.	183,692	$2.98M	0.0%	+3.1%	0.421%
2/10/2022	Qube Research & Technologies Ltd	15,577	$0.25M	0.0%	N/A	0.036%
2/10/2022	Rafferty Asset Management LLC	76,576	$1.24M	0.0%	+88.7%	0.175%
2/10/2022	Citigroup Inc.	67,755	$1.10M	0.0%	+113.4%	0.155%
2/9/2022	BNP Paribas Arbitrage SA	9,100	$0.15M	0.0%	+41.1%	0.021%
2/9/2022	Alps Advisors Inc.	50,503	$0.82M	0.0%	-5.4%	0.116%
2/9/2022	Dimensional Fund Advisors LP	191,802	$3.11M	0.0%	+52.8%	0.439%
2/8/2022	Northern Trust Corp	343,987	$5.58M	0.0%	-0.9%	0.788%
2/7/2022	SG Americas Securities LLC	15,020	$0.24M	0.0%	-41.8%	0.034%
2/3/2022	Advisor Group Holdings Inc.	4,159	$67K	0.0%	N/A	0.010%
2/2/2022	New York State Common Retirement Fund	236,284	$3.83M	0.0%	-21.8%	0.541%
2/1/2022	Qube Research & Technologies Ltd	15,577	$0.25M	0.0%	N/A	0.036%
1/28/2022	Allspring Global Investments Holdings LLC	15,063	$0.24M	0.0%	N/A	0.035%
1/21/2022	Russell Investments Group Ltd.	64,404	$1.04M	0.0%	+77.5%	0.148%
1/12/2022	DNB Asset Management AS	13,367	$0.22M	0.0%	+6.4%	0.031%
11/16/2021	Migdal Insurance & Financial Holdings Ltd.	1,720	$49K	0.0%	N/A	0.004%
11/16/2021	Brookfield Asset Management Inc.	179,236	$5.12M	0.0%	+7.5%	0.411%
11/16/2021	Two Sigma Advisers LP	49,000	$1.40M	0.0%	-63.8%	0.112%
11/16/2021	Wellington Management Group LLP	4,278,097	$122.10M	0.0%	-3.8%	9.802%
11/16/2021	BioImpact Capital LLC	452,970	$12.93M	2.0%	+34.3%	1.038%
11/15/2021	Point72 Hong Kong Ltd	995	$28K	0.0%	N/A	0.002%
11/15/2021	Cubist Systematic Strategies LLC	14,884	$0.43M	0.0%	N/A	0.034%
11/15/2021	California State Teachers Retirement System	40,232	$1.15M	0.0%	-16.5%	0.092%
11/15/2021	Oracle Investment Management Inc.	315,642	$9.01M	1.1%	+5.0%	0.723%
11/15/2021	Virtus ETF Advisers LLC	12,578	$0.36M	0.2%	-8.4%	0.029%
11/15/2021	Polar Capital Holdings Plc	1,154,961	$32.96M	0.1%	+97.1%	2.646%
11/15/2021	Dimensional Fund Advisors LP	125,522	$3.58M	0.0%	N/A	0.288%
11/15/2021	Ensign Peak Advisors Inc	6,043	$0.17M	0.0%	-73.3%	0.014%
11/15/2021	Lombard Odier Asset Management Switzerland SA	352,839	$10.07M	0.6%	+10.3%	0.808%
11/12/2021	Brandywine Global Investment Management LLC	32,537	$0.93M	0.0%	N/A	0.075%
11/12/2021	The Manufacturers Life Insurance Company	18,856	$0.54M	0.0%	-6.6%	0.043%
11/12/2021	Credit Suisse AG	16,942	$0.48M	0.0%	+8.8%	0.039%
11/12/2021	CNA Financial Corp	13,760	$0.39M	0.1%	+3.5%	0.032%
11/12/2021	Geode Capital Management LLC	577,111	$16.47M	0.0%	+4.7%	1.322%

Data available starting January 2016

Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment of pediatric patients with relapsed or refractory high-risk neuroblastoma. The company is also developing DANYELZA that is in Phase II clinical studies for the treatment of patients with first-line neuroblastoma, third-line neuroblastoma, and in relapsed osteosarcoma; GD2-GD3 vaccine that is in Phase II clinical trial for the treatment of Stage 4 high-risk neuroblastoma; and Omburtamab, a murine monoclonal antibody that is in clinical trials for the treatment of central nervous system/ leptomeningeal metastases from neuroblastoma, desmoplastic small round cell tumor, diffuse intrinsic pontine glioma, and other B7-H3 positive tumors. In addition, it is developing Nivatrotamab for the treatment of small cell lung cancer, as well as is in Phase I/II trial for the treatment of refractory GD2 positive adult and pediatric solid tumors; and Lu-omburtamab-DTPA that is in Phase I clinical development for the treatment of medulloblastoma and B7-H3 positive leptomeningeal metastases from solid tumors. The company has a license agreement with Memorial Sloan Kettering Cancer Center and Massachusetts Institute of Technology to develop and commercialize licensed products. Y-mAbs Therapeutics, Inc. was incorporated in 2015 and is headquartered in New York, New York.

Today's Range

Now: $18.30

$17.15

$18.47

50 Day Range

MA: $15.83

$10.80

$19.67

52 Week Range

Now: $18.30

$6.50

$34.60

Volume

228,675 shs

Average Volume

270,032 shs

Market Capitalization

$800.08 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.15

Who are the company insiders with the largest holdings of Y-mAbs Therapeutics?: Y-mAbs Therapeutics' top insider shareholders include:
Johan Wedell-Wedellsborg (Director)
Biotech Aps Wg (Major Shareholder)
Biotech Aps Wg (Director)
Bo Kruse (CFO)
Thomas Gad (Insider)
Pedro Claus Juan Moller-San (CEO)
Thomas Gad (Chairman)
David N Gill (Director)
Vignesh Rajah (CMO)
Learn More about top insider investors at Y-mAbs Therapeutics.
Who are the major institutional investors of Y-mAbs Therapeutics?: Y-mAbs Therapeutics' top institutional shareholders include:
FMR LLC — 4.51%
Walleye Capital LLC — 0.95%
Northern Trust Corp — 0.76%
Renaissance Technologies LLC — 0.34%
Rice Hall James & Associates LLC — 0.21%
Swiss National Bank — 0.18%
Learn More about top institutional investors of Y-mAbs Therapeutics stock.
Which major investors are selling Y-mAbs Therapeutics stock?: During the previous quarter, YMAB stock was sold by these institutional investors:
Deutsche Bank AG
UBS Group AG
Rafferty Asset Management LLC
Allspring Global Investments Holdings LLC
JPMorgan Chase & Co.
Brandywine Global Investment Management LLC
During the previous year, company insiders that have sold Y-mAbs Therapeutics company stock include:
Johan Wedell-Wedellsborg (Director)
Biotech Aps Wg (Major Shareholder)
Learn More investors selling Y-mAbs Therapeutics stock.
Which major investors are buying Y-mAbs Therapeutics stock?: Within the last quarter, YMAB stock was purchased by institutional investors including:
Walleye Capital LLC
Renaissance Technologies LLC
Ensign Peak Advisors Inc
SG Americas Securities LLC
Swiss National Bank
DnB Asset Management AS
Mirae Asset Global Investments Co. Ltd.
Principal Financial Group Inc.